INM Inmed Pharmaceuticals Inc.

Fundamentals / CIK 0001728328 / USD
Other share classes on CIK 0001728328: MTRI

Inmed Pharmaceuticals Inc. reported $1.31M in total assets and a net loss of $13.16M through June 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open INM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2020 to 2026), reported in USD.

$6.84M$3.42M$0-$17.81MFY 2020 Net Income: -$8.94M2020FY 2021 Revenue: $1.90MFY 2021 Net Income: -$10.20M2021FY 2022 Revenue: $1.09MFY 2022 Net Income: -$18.60M2022FY 2023 Revenue: $4.14MFY 2023 Net Income: -$7.95M2023FY 2024 Revenue: $4.60MFY 2024 Net Income: -$7.68M2024FY 2025 Revenue: $4.94MFY 2025 Net Income: -$1.70M2025FY 2026 Net Income: -$12.56M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Revenue -- $4.94M $4.60M $4.14M $1.09M $1.90M --
Cost of Revenue -- $3.24M $3.50M $2.73M $546K -- --
Gross Profit -- $1.71M $1.10M $1.40M $544K -- --
Research & Development $3.03M $2.82M $3.22M $3.73M $7.28M $5.34M $5.81M
Total Operating Expenses $11.61M $8.47M $9.30M $9.83M $17.81M $9.94M $9.15M
Operating Income -- -$6.77M -$8.20M -$7.95M -$18.60M -$10.20M --
EBITDA -- -$6.56M -$7.98M -$7.75M -$18.41M -$10.08M --
Interest Income $245K $156K $528K $492K $96K $16K $130K
Income Before Tax -$11.37M -$8.69M -$7.67M -$7.93M -$18.60M -- --
Income Tax Expense -- -- $7.1K $13K -- -- --
Net Income -$12.56M -$1.70M -$7.68M -$7.95M -$18.60M -$10.20M -$8.94M
Basic EPS -$3.12 -$8.36 -$20.14 -$65.00 -$663.40 -$759.20 -$34.20
Diluted EPS -$3.12 -$8.36 -$20.14 -$65.00 -$663.40 -$759.20 -$34.20
Basic Shares Outstanding 4.2M 975.9K 381.1K 122.4K 28.0K 13.4K 261.0K
Diluted Shares Outstanding 4.2M 975.9K 381.1K 122.4K 28.0K 13.4K 261.0K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- $820K $1.12M $1.30M $1.26M $1.11M
Cost of Revenue -- -- -- $636K $717K $728K $1.09M $651K
Gross Profit -- -- -- $184K $403K $577K $176K $461K
Research & Development $206K $806K $1.02M $631K $575K $577K $425K $895K
Total Operating Expenses $2.01M $4.86M $2.84M $2.29M $1.92M $1.87M $2.08M $2.71M
Operating Income -- -- -- -$2.10M -$1.52M -$1.29M -$1.91M -$2.25M
EBITDA -- -- -- -$2.05M -$1.47M -$1.24M -$1.86M -$2.20M
Interest Income $14K $29K $48K $74K $94K $52K $17K $31K
Income Before Tax -$2.00M -$4.84M -$2.79M -$2.03M -$1.83M -$1.83M -$2.07M -$2.58M
Net Income -$2.33M -$5.84M -$2.97M -$2.03M -$1.73M $4.67M -$2.12M -$2.58M
Basic EPS -$0.42 -- -$0.73 -$0.51 -$0.44 -- -$1.94 -$3.64
Diluted EPS -$0.42 -- -$0.73 -$0.51 -$0.44 -- -$1.94 -$3.64
Basic Shares Outstanding 5.5M -- 4.0M 4.0M 4.0M -- 1.1M 706.5K
Diluted Shares Outstanding 5.5M -- 4.0M 4.0M 4.0M -- 1.1M 706.5K

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Cash & Cash Equivalents -- $10.74M $6.57M $8.91M $6.18M $7.36M $5.81M
Short-Term Investments $40K $43K $43K $44K $45K $46K $42K
Cash & Short-Term Investments $2.20M $11.10M $6.60M $8.96M $6.22M $7.41M $5.85M
Accounts Receivable, Net -- $465K $353K $260K $88K $12K $45K
Inventory -- $961K $1.24M $1.62M $2.49M -- --
Total Current Assets $2.68M $12.87M $8.69M $11.33M $9.60M $8.38M $6.31M
Property, Plant & Equipment, Net $221K $992K $1.25M $723K $904K $327K $403K
Intangible Assets -- $1.62M $1.78M $1.95M $2.11M $1.06M $1.09M
Other Non-Current Assets $132K $100K $100K $105K $177K $15K --
Total Non-Current Assets $353K $2.71M $3.13M $2.77M $3.19M $1.40M $1.49M
Total Assets $3.03M $15.58M $11.82M $14.11M $12.79M $9.78M $7.80M
Accounts Payable $927K $278K $41K $544K $1.17M -- --
Other Current Liabilities -- -- -- -- $3.18M $2.22M --
Total Current Liabilities $1.96M $1.84M $1.97M $2.00M $3.32M $2.22M $1.68M
Total Non-Current Liabilities $0 $306K $645K $16K $389K $189K $248K
Total Liabilities $1.96M $2.15M $2.62M $2.02M $3.71M $2.40M $1.92M
Total Debt (incl. Leases) -- $741K $963K $392K $825K $385K $317K
Common Stock $94.28M $91.22M $82.78M $77.62M $70.72M $60.59M $53.07M
Retained Earnings -$130.2M -$117.2M -$109.1M -$101.4M -$93.45M -$74.85M -$64.65M
Accumulated Other Comp. Income $129K $129K $129K $129K $129K $129K -$302K
Total Stockholders' Equity $1.08M $13.43M $9.21M $12.09M $9.08M $7.38M $5.88M
Total Equity $1.08M $13.43M $9.21M $12.09M $9.08M $7.38M $5.88M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents -- -- $5.16M $6.95M $9.33M $10.74M $4.68M $3.42M
Short-Term Investments $40K $40K $42K $43K $43K $43K $41K $41K
Cash & Short-Term Investments $1.10M $2.20M $5.20M $7.00M $9.40M $11.10M $4.70M $3.50M
Accounts Receivable, Net -- -- -- $183K $343K $465K $368K $263K
Inventory -- -- -- $948K $891K $961K $814K $1.10M
Total Current Assets $1.26M $2.68M $6.89M $8.79M $10.80M $12.87M $6.41M $5.47M
Property, Plant & Equipment, Net -- $221K $643K $764K $882K $992K $1.11M $1.23M
Intangible Assets -- -- $1.50M $1.54M $1.58M $1.62M $1.66M $1.70M
Other Non-Current Assets $42K $132K $104K $100K $100K $100K $100K $100K
Total Non-Current Assets $42K $353K $2.25M $2.40M $2.56M $2.71M $2.87M $3.03M
Total Assets $1.31M $3.03M $9.13M $11.19M $13.36M $15.58M $9.28M $8.50M
Accounts Payable $1.67M $927K $225K $167K $369K $278K $560K $575K
Total Current Liabilities -- $1.96M $2.21M $1.48M $1.55M $1.84M $1.84M $1.79M
Total Non-Current Liabilities -- $0 $31K $124K $215K $306K $419K $529K
Total Liabilities $2.51M $1.96M $2.24M $1.60M $1.77M $2.15M $2.26M $2.32M
Total Debt (incl. Leases) -- -- $420K $532K $640K $741K $849K $949K
Common Stock $94.41M $94.28M $92.58M $92.05M $91.81M $91.22M $87.46M $84.54M
Retained Earnings -$132.6M -$130.2M -$124.0M -$121.0M -$119.0M -$117.2M -$115.4M -$113.3M
Accumulated Other Comp. Income $129K $129K $129K $129K $129K $129K $129K $129K
Total Stockholders' Equity -$1.20M $1.08M $6.89M $9.59M $11.59M $13.43M $7.02M $6.18M
Total Equity -$1.20M $1.08M $6.89M $9.59M $11.59M $13.43M $7.02M $6.18M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Net Income -$12.56M -$1.70M -$7.68M $7.90M $18.60M $10.20M $8.90M
Depreciation & Amortization $205K $213K $220K $202K $186K $121K $112K
Stock-Based Compensation $107K $119K $138K $278K $698K $610K $994K
Change in Receivables -- -$115K -$92K -$219K -$40K $40K $17K
Change in Inventory -- $283K $66K $566K -$2.00M -- --
Operating Cash Flow -$8.64M -$8.10M -$6.99M -$7.28M -$15.58M -$9.79M -$7.37M
Capital Expenditure -- -- -$9.3K -$160K -$39K -$1.7K -$43K
Free Cash Flow -- -- -$7.00M -$7.44M -$15.62M -$9.79M -$7.42M
Acquisitions, Net -- -- -- -$500K -- -- --
Investing Cash Flow -- -- -$9.3K -$662K -$673K -$1.7K $3.79M
Common Stock Issued -- -- -- $12.00M $17.15M $12.47M --
Financing Cash Flow $94K $12.27M $4.65M $10.68M $15.07M $10.85M -$31K
Net Change in Cash -$8.55M $4.17M -$2.34M $2.74M -$1.19M $1.56M -$4.03M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$2.33M -$5.84M -$2.97M -$2.03M -$1.73M $4.67M -$2.12M -$2.58M
Depreciation & Amortization $168 $48K $51K $53K $53K $53K $52K $53K
Stock-Based Compensation $16K $23K $39K $25K $20K $27K $40K $23K
Change in Receivables -- -- -- $160K $122K -$100K -$105K $23K
Change in Inventory -- -- -- -$127K $70K -$147K $289K $117K
Operating Cash Flow -$1.14M -$2.96M -$1.70M -$2.05M -$1.93M -$2.11M -$1.66M -$2.50M
Investing Cash Flow $2.4K -- -- -- -- -- -- --
Financing Cash Flow $40K -$1 $232K $0 -$137K $8.17M $2.92M $339K
Net Change in Cash -$1.10M -$2.96M -$1.46M -$2.05M -$2.07M $6.06M $1.26M -$2.16M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30 Jun 30
Gross Margin -- 34.5% 23.9% 33.9% 49.9% -- --
Operating Margin -- -136.9% -178.3% -192.2% -1707.3% -535.9% --
Net Profit Margin -- -34.4% -166.9% -192.2% -1707.3% -535.9% --
Return on Equity (ROE) -1168.4% -12.7% -83.4% -65.7% -204.9% -138.3% -152.1%
Return on Assets (ROA) -414.5% -10.9% -64.9% -56.3% -145.5% -104.3% -114.6%
Current Ratio 1.37x 6.99x 4.41x 5.66x 2.89x 3.78x 3.77x
Quick Ratio 1.13x 6.47x 3.78x 4.86x 2.14x 3.35x 3.52x
Debt to Equity -- 0.06x 0.10x 0.03x 0.09x 0.05x 0.05x
Revenue Growth (YoY) -- +7.5% +11.2% +279.6% -42.8% -- --
Gross Profit Growth (YoY) -- +55.0% -21.5% +158.1% -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin -- -- -- 29.7% 33.7% 34.5% 32.4% 35.4%
Operating Margin -- -- -- -151.4% -145.3% -145.4% -161.2% -162.8%
Net Profit Margin -- -- -- -26.7% -36.5% -34.4% -168.9% -163.8%
Return on Equity (ROE) -- -1168.4% -29.7% -12.5% -15.1% -12.7% -118.4% -128.0%
Return on Assets (ROA) -1008.1% -414.5% -22.4% -10.7% -13.1% -10.9% -89.6% -93.1%
Current Ratio -- 1.37x 3.11x 5.94x 6.95x 6.99x 3.49x 3.05x
Quick Ratio -- 1.13x 2.35x 5.30x 6.37x 6.47x 3.04x 2.44x
Debt to Equity -- -- 0.06x 0.06x 0.06x 0.06x 0.12x 0.15x
Revenue Growth (YoY) -- -- -- -26.2% -11.4% +1.7% +7.6% -10.4%
Gross Profit Growth (YoY) -- -- -- -60.0% -18.3% +23.7% -39.3% +42.2%
Net Income Growth (YoY) -- -224.9% -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001728328) · from September 30, 2019 Data through September 30, 2026 · synced Nov 21, 2026, 05:07 UTC · Open in terminal